Q2 Solutions understands that bringing a promising drug candidate to market requires a well-planned strategy that incorporates sensitive, specific, and validated assays to inform development decisions. As such, our highly trained scientists apply leading-edge technologies, automated platforms, and state-of-the-art techniques to support a wide range of bioanalytical services and ADME services.
From high-throughput ADME screening services and human clearance predictions to support drug metabolism and pharmacokinetics studies to drug-drug interaction testing and metabolite profiling to support clinical safety, the Q2 Solutions global network offers solutions to support every phase of drug discovery and development.
Our bioanalysis services include:
In addition to specific services detailed in the sections below, Q2 Solutions can provide bundled services for discovery and regulatory-phase packages to enable decision-making at each step of the development process.
Q2 Solutions is a leading drug discovery and development laboratory services organization with over 30 years of experience specializing in GLP-compliant bioanalytical testing. Our updated and...
The analysis and distribution of pharmaceuticals in tissue is increasingly important in understanding the full action of drugs in vivo. Across molecular types from very small molecules to larger...
Q2 Solutions offers tailored and comprehensive small molecule bioanalytical and ADME laboratory services. We combine scientific excellence, high-quality project management, and outstanding delivery...